Why Healthcare Needs More Physician Entrepreneurs | Dr. Alison Curfman

In a recent episode of Digital Health Interviews, we sat down with Dr. Alison Curfman, MD, MBA, pediatric emergency physician, co-founder of Imagine Pediatrics, and founder of Startup Physicians, to discuss one of the most frustrating contradictions in American healthcare: why innovations that improve patient outcomes and save millions of dollars can still fail commercially.

Curfman's experience sits at the intersection of clinical medicine, healthcare entrepreneurship, and business strategy. She has helped develop virtual pediatric care programs, built a value-based care company serving children covered by Medicaid, and now supports physicians who want to move beyond traditional clinical roles into entrepreneurship. Her career illustrates a challenge that many digital health founders eventually encounter: demonstrating that a solution works is not the same as proving that the healthcare system will pay for it.

Throughout the conversation, Curfman explores the economic incentives that shape healthcare innovation, the growing dissatisfaction among physicians, and the opportunities and risks emerging as artificial intelligence enters clinical practice. Her central message is particularly relevant for healthcare startups: better technology and stronger clinical outcomes matter, but neither guarantees a sustainable business.

When Better Healthcare Doesn't Make Business Sense

One of the most revealing experiences Curfman shares concerns a virtual pediatric care program that delivered impressive clinical and financial results but ultimately lost funding. The program reduced hospitalizations by 35% and emergency department visits by nearly 50%, generating substantial savings for insurers while helping children receive care without unnecessary hospital visits.

By conventional measures of healthcare innovation, the program appeared successful. Patients benefited from improved access to care, unnecessary utilization declined, and the organizations financing healthcare avoided significant expenses. Yet those results were not enough to secure the program's future. The problem was not clinical performance. It was the business model.

This experience highlights a structural contradiction within American healthcare. The organizations that benefit financially from improved outcomes are not always the same organizations responsible for financing the interventions that produce them. A program can generate substantial savings across the healthcare system without establishing a reliable mechanism for capturing enough of that value to remain operational.

For digital health founders, this distinction is critical. Clinical validation demonstrates that a product can improve care, but commercial viability depends on understanding who pays, who benefits, how savings are measured, and whether those incentives remain aligned over time. Without a sustainable financial arrangement, even a clinically effective solution can struggle to survive.

Why Healthcare's Incentives Work Against Innovation

The difficulties Curfman encountered are not unique to pediatric care. They reflect broader problems within a healthcare system where payment structures, organizational priorities, and patient needs frequently pull in different directions.

Traditional fee-for-service reimbursement rewards the delivery of individual services rather than necessarily rewarding the prevention of future medical interventions. Hospitals receive payments for admissions and procedures, while preventive care programs may struggle to secure comparable financial support, even when they reduce overall spending.

This creates a difficult environment for companies attempting to introduce fundamentally different models of care. A startup may demonstrate that its technology reduces emergency department utilization or prevents avoidable hospitalizations, yet still face resistance from organizations whose financial incentives are tied to existing patterns of service delivery.

The challenge becomes even more complicated when multiple stakeholders are involved. Health plans, providers, employers, patients, and government programs may all benefit differently from the same intervention. A solution that creates measurable value for one stakeholder may not immediately support the business objectives of another.

Curfman's experience demonstrates why healthcare innovation requires more than identifying inefficiencies. Founders must understand the economic relationships that allow those inefficiencies to persist and develop business models capable of operating within, or meaningfully changing, those structures.

Building Imagine Pediatrics Around a Different Model of Care

The lessons from Curfman's earlier experience helped shape her subsequent work as a co-founder of Imagine Pediatrics, a virtual-first, value-based care company serving more than 100,000 children covered by Medicaid, according to the interview description.

Imagine Pediatrics represents an approach to care delivery that differs from traditional models centered on individual appointments and hospital-based interventions. Rather than treating virtual care as an isolated service, the company's model focuses on supporting children and families through a broader, coordinated care experience.

This distinction matters because children with complex healthcare needs often require ongoing attention from multiple providers. Families may face difficulties navigating appointments, managing chronic conditions, accessing specialists, and determining when an emergency department visit is necessary.

Virtual-first care can help address some of these challenges by making clinical support more accessible and allowing care teams to remain involved between traditional appointments. However, the underlying business model is equally important.

Value-based care arrangements seek to connect financial incentives with quality, outcomes, and the management of healthcare costs. For companies like Imagine Pediatrics, the opportunity is not simply to deliver more convenient appointments but to create a sustainable model in which preventing unnecessary utilization becomes financially meaningful.

The broader lesson is that healthcare innovation becomes more viable when the delivery model and payment structure support the same objectives. Technology can enable more accessible care, but the business model determines whether that approach can continue operating at scale.

Why Traditional Healthcare Organizations Struggle to Change

Another important theme in the conversation is the difficulty of introducing innovation into established healthcare organizations.

Large health systems possess clinical expertise, infrastructure, patient relationships, and significant operational resources. Yet these advantages do not necessarily make them well positioned to adopt new models of care.

Healthcare organizations operate within complex financial and regulatory environments. Their existing workflows, reimbursement arrangements, staffing structures, and technology investments create dependencies that are difficult to change. Even when leadership recognizes the potential benefits of a new solution, implementation may require coordination across departments with different priorities.

For startups, this creates a challenge that extends far beyond product development. A healthcare organization may express enthusiasm for an innovative platform while struggling to identify a budget, establish an implementation process, or determine which department should take responsibility for the investment. The gap between organizational interest and actual adoption can be substantial.

Curfman's experiences suggest that founders need to evaluate not only whether healthcare organizations need their products, but also whether those organizations have the financial incentives, operational capacity, and internal alignment required to implement them.

In healthcare, the ability to navigate existing systems can be just as important as the ability to develop something new.

Could Direct Primary Care Offer a Better Alternative?

The discussion also explores direct primary care as an alternative to conventional healthcare financing.

Under a direct primary care model, patients typically pay a recurring membership fee for access to a defined range of primary care services. This arrangement reduces reliance on traditional fee-for-service billing and can give physicians greater flexibility in how they organize their practices.

For clinicians, the appeal lies partly in the possibility of spending more time with patients while reducing administrative responsibilities associated with insurance billing. For patients, the model can offer more predictable costs and a more direct relationship with their physician.

However, direct primary care is not a complete replacement for health insurance. Patients may still require separate coverage for hospitalizations, specialist treatment, medications, and other services outside the membership arrangement. Affordability and accessibility also remain important considerations, particularly for populations with limited financial resources.

The relevance of direct primary care to the broader conversation is its willingness to reconsider how healthcare services are financed and delivered.

Rather than assuming that every improvement must fit within existing reimbursement structures, alternative models create opportunities to redesign the relationship between patients, providers, and payment systems.

For entrepreneurs, the lesson is not that one model will solve every healthcare problem. It is that business model innovation deserves as much attention as technological innovation.

Physician Burnout Is Becoming an Entrepreneurship Story

Curfman's work also addresses another major challenge facing American healthcare: the growing number of physicians questioning whether they want to remain in traditional clinical practice.

Burnout is frequently discussed as a workforce problem, but its consequences extend beyond individual job satisfaction. When experienced physicians reduce their clinical hours, leave medicine, or become disengaged from their work, healthcare organizations lose valuable expertise while patients face additional challenges accessing care.

The reasons behind physician dissatisfaction are complex. Administrative responsibilities, documentation requirements, limited professional autonomy, financial pressures, and demanding schedules can all contribute to a sense that practicing medicine has become increasingly disconnected from the reasons clinicians entered the profession. Yet Curfman sees another dimension to this problem.

Physicians possess extensive knowledge of clinical workflows, patient needs, healthcare inefficiencies, and the practical limitations of existing technologies. Those experiences can become valuable assets outside conventional clinical roles, particularly in healthcare startups, product development, consulting, and advisory positions.

Through Startup Physicians, Curfman helps doctors explore opportunities to become entrepreneurs, startup advisors, and founders. The initiative reflects a growing recognition that medical expertise can contribute to healthcare innovation in many forms beyond direct patient care.

Rather than viewing entrepreneurship simply as an escape from medicine, this perspective positions physicians as potential architects of better healthcare systems.

Why Healthcare Startups Need Physicians at the Table

One of the recurring challenges in digital health is the distance between the people building technology and the clinicians expected to use it.

Healthcare startups often begin with strong engineering capabilities, promising AI models, or innovative business concepts. However, without sufficient clinical involvement, teams can overlook important details about patient safety, workflow complexity, professional responsibilities, and the realities of delivering care.

A product may appear efficient in a demonstration but create additional work when introduced into a busy clinical environment. A feature designed to improve communication may fail to account for how physicians prioritize urgent information. An AI-generated recommendation may be technically sophisticated but poorly suited to the decisions clinicians actually need to make.

Physician involvement helps identify these problems before they become expensive implementation failures.

Clinicians can contribute to product strategy, clinical validation, workflow design, risk assessment, and customer discovery. Their expertise is particularly important when a solution influences clinical decisions or interacts directly with patients.

At the same time, medical knowledge alone does not guarantee entrepreneurial success. Physicians entering the startup ecosystem must learn to evaluate markets, understand customer incentives, build financially sustainable businesses, and communicate value to stakeholders outside clinical medicine.

The strongest healthcare companies are often those capable of bringing these perspectives together rather than treating clinical expertise and business strategy as separate disciplines.

AI Could Transform Medicine, but Clinical Oversight Still Matters

Artificial intelligence introduces another layer of complexity to the future of healthcare entrepreneurship.

AI systems are becoming increasingly capable of processing medical information, supporting documentation, assisting with administrative tasks, and generating insights that can inform clinical workflows. These capabilities create opportunities to reduce repetitive work and improve how healthcare professionals access and use information.

For physicians already overwhelmed by administrative responsibilities, AI could offer meaningful relief. Documentation support, information retrieval, and workflow automation may allow clinicians to devote more attention to patient care.

However, Curfman's discussion also highlights the risks of deploying AI without appropriate clinical oversight.

Healthcare decisions involve uncertainty, incomplete information, and consequences that can directly affect patient safety. AI-generated outputs may appear confident even when they contain inaccuracies or fail to account for important clinical context.

That makes physician involvement essential, particularly for tools that support diagnosis, treatment planning, or other clinically significant decisions.

AI should not be evaluated solely by how much work it automates. Healthcare organizations also need to consider how their outputs are validated, how errors are identified, when clinicians should intervene, and who remains accountable for decisions affecting patients.

For founders developing healthcare AI products, clinical oversight is not simply a regulatory obstacle. It is a fundamental requirement for building technology that healthcare professionals can responsibly adopt.

Clinical Evidence Is Necessary, but It Isn't Enough

Toward the end of the conversation, Curfman's experience offers a practical lesson for founders attempting to build sustainable healthcare businesses. A compelling idea is only the beginning.

Startups need to demonstrate that their products address meaningful problems, produce measurable results, and fit within a viable commercial model. In healthcare, these requirements are especially demanding because customers may need clinical evidence, financial justification, operational validation, and regulatory assurances before committing to a new solution.

Clinical outcomes are an essential part of that process. Reducing hospitalizations, improving access, or helping clinicians work more efficiently can provide strong evidence of value.

But Curfman's earlier experience shows why evidence must be connected to a clear business strategy.

Founders need to identify the stakeholder responsible for purchasing the solution and understand what that stakeholder considers success. They must also determine whether the value they create can be translated into sustainable revenue.

A product that saves an insurer millions of dollars may still fail if the commercial arrangement does not allow the company delivering those savings to remain financially viable.

This is why customer discovery, reimbursement strategy, pricing, and financial sustainability should be considered early in healthcare product development rather than postponed until after clinical validation.

Building Healthcare Companies That Can Actually Scale

The conversation with Dr. Alison Curfman ultimately reveals a broader problem in healthcare innovation: the industry often treats clinical success, technological progress, and commercial sustainability as separate objectives. In reality, they are deeply connected.

A healthcare startup can develop excellent technology and demonstrate meaningful improvements in patient outcomes, yet still fail because its business model does not align with the incentives of its customers. Similarly, an organization may establish a profitable service without creating the improvements in care that patients genuinely need.

Sustainable healthcare innovation requires both.

Curfman's journey, from developing virtual pediatric care programs to co-founding Imagine Pediatrics and helping physicians become entrepreneurs through Startup Physicians, illustrates why understanding healthcare economics is essential to creating lasting change.

It also demonstrates the importance of involving clinicians in the development of new healthcare solutions. Physicians understand the practical challenges of care delivery, but turning that expertise into scalable innovation requires business knowledge, technological capabilities, and a willingness to rethink established models.

As AI becomes more deeply integrated into healthcare, these lessons will become even more relevant. The next generation of successful health tech companies will not necessarily be those introducing the most sophisticated technologies. They will be those capable of proving clinical value, earning trust, aligning financial incentives, and building sustainable businesses around better patient care.

Because in healthcare, creating value is only half the challenge. The other half is building a system that can sustain it.